BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2017
View Archived Issues
Gene-corrected hematopoietic stem-progenitor cells to treat infantile neuronal ceroid lipofuscinosis
Read More
FDA grants orphan drug designation to RASRx-1902 for Duchenne muscular dystrophy
Read More
Scripps Research Institute announces USD 7 million grant to develop new therapies for ALS
Read More
Recordati licenses neurotrophic keratitis candidate from MimeTech
Read More
Boehringer Ingelheim presents first-in-human results for BI-894999
Read More
Bristol-Myers Squibb TYK2 inhibitor BMS-986165 promising in phase I trial
Read More
Human pluripotent stem cells used for cartilage repair in animal models
Read More
ALRN-6924 demonstrates clinical antitumor activity across a variety of wild-type TP53 tumors
Read More
Topline data update for phase III clinical study of hGH-CTP in adults with growth hormone deficiency
Read More
Phase III trial of anlotinib as third-line treatment for NSCLC meets primary endpoint
Read More
Abide Therapeutics divulges novel MGL/FAAH inhibitors
Read More
Selecta Biosciences announces data from phase II study of SEL-212 for gout
Read More
Novel LRRK2 inhibitors patented by Denali Therapeutics
Read More
Janssen R&D Ireland synthesizes new anti-influenza compounds
Read More
Taiho Pharmaceutical patents KDM1A inhibitors
Read More
Basilea Pharmaceutica presents new bacterial efflux pump inhibitors
Read More
Immunocore and Adaptimmune describe novel SLC45A2-derived peptides
Read More
NIA selects CDX-085 for its anti-aging Interventions Testing Program
Read More
FDA expands approved use of Ipsen's Dysport
Read More
New phase IIa study evaluates OPB-111077 in advanced refractory cancers
Read More
Agilent announces expanded use of PD-L1 IHC 28-8 pharmDx test
Read More
Incyte initiates phase I study of INCB-062079 in HCC and other malignancies
Read More
Novartis presents data for the novel antibacterial agent LYS-228
Read More
Genmab reports data from cervical cancer cohort of phase I/II study of tisotumab vedotin
Read More
GamLPV vaccine for prevention of whooping cough studied in new phase I trial
Read More
Seikagaku initiates phase II study in U.S. with SI-613 for knee osteoarthritis
Read More
Intrexon completes acquisition of GenVec
Read More